{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:18:02Z","timestamp":1790709482504,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What are the sperm and egg donor rejection rates after expanded carrier screening (ECS)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>Using an ECS panel looking at 46\/47 genes, 17.6% of donors were rejected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>The use of ECS is becoming commonplace in assisted reproductive technology, including testing of egg and sperm donors. Most national guidelines recommend rejection of donors if they are carriers of a genetic disease. If the use of ECS increases, there will be a decline in the number of donors available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>A review of the current preconception ECS panels available to donors was carried out through an online search. The genetic testing results of donors from Cryos International were analysed to determine how many were rejected on the basis of the ECS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Data on gamete donors and their carrier status was provided by Cryos International, who screen donors using their own bespoke ECS panel. The ECS panels identified through the review were compared to the Cryos International panel and data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>A total of 16 companies and 42 associated ECS panels were reviewed. There were a total of 2673 unique disorders covered by the panels examined, with a mean of 329 disorders screened. None of these disorders were common to all panels. Cryos International screen 46 disorders in males and 47 in females. From 883 candidate donors, 17.6% (155\/883) were rejected based on their ECS result. Carriers of alpha-thalassaemia represented the largest proportion of those rejected (19.4%, 30\/155), then spinal muscular atrophy (15.5%, 24\/155) and cystic fibrosis (14.8%, 23\/155).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>Panel information was found on company websites and may not have been accurate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>This study highlights the need for consistent EU regulations and guidelines that allow genetic matching of gamete donors to their recipients, preventing the need to reject donors who are known carriers. A larger ECS panel would be most beneficial; however, this would not be viable without matching of donors and recipients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>No specific funding was obtained. J.C.H. is the founder of Global Women Connected, a platform to discuss women\u2019s health issues and the Embryology and PGD Academy, who deliver education in clinical embryology. She has been paid to give a lecture by Cryos in 2019. A-B.S. is an employee of Cryos International.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deab067","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T20:13:03Z","timestamp":1615407183000},"page":"1702-1710","source":"Crossref","is-referenced-by-count":32,"title":["The use of expanded carrier screening of gamete donors"],"prefix":"10.1093","volume":"36","author":[{"given":"Molly R","family":"Payne","sequence":"first","affiliation":[{"name":"Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Bine","family":"Skytte","sequence":"additional","affiliation":[{"name":"Cryos International, Denmark ApS, Aarhus C, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6364-2367","authenticated-orcid":false,"given":"Joyce C","family":"Harper","sequence":"additional","affiliation":[{"name":"Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,11]]},"reference":[{"key":"2021070807482399700_deab067-B1","author":"American College of Obstetricians and Gynecologists (ACOG). Carrier Screening for Genetic Conditions","year":"2017"},{"key":"2021070807482399700_deab067-B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12978-018-0468-9","article-title":"Attitudes of sperm, egg and embryo donors and recipients towards genetic information and screening of donors","volume":"15","author":"Amor","year":"2018","journal-title":"Reprod Health"},{"key":"2021070807482399700_deab067-B3","author":"Arbeitskreises f\u00fcr Donogene Insemination","year":"2006"},{"key":"2021070807482399700_deab067-B4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/jcm3031033","article-title":"Carrier screening: past, present, and future","volume":"3","author":"Bajaj","year":"2014","journal-title":"J Clin Med"},{"key":"2021070807482399700_deab067-B5","doi-asserted-by":"crossref","first-page":"65ra4","DOI":"10.1126\/scitranslmed.3001756","article-title":"Carrier testing for severe childhood recessive diseases by next-generation sequencing","volume":"3","author":"Bell","year":"2011","journal-title":"Sci Transl Med"},{"key":"2021070807482399700_deab067-B6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.11138\/cce\/2017.4.2.052","article-title":"Genetic matching between recipients and oocyte donors","volume":"4","author":"Boada","year":"2017","journal-title":"Curr Trends Clin Embryol"},{"key":"2021070807482399700_deab067-B7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1163\/15718093-12341409","article-title":"The legalisation of gamete donation in Italy","volume":"24","author":"Boggio","year":"2017","journal-title":"Eur J Health Law"},{"key":"2021070807482399700_deab067-B9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bpobgyn.2017.02.006","article-title":"Growing complexity of (expanded) carrier screening: direct-to-consumer, physician-mediated, and clinic-based offers","volume":"44","author":"Chokoshvili","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2021070807482399700_deab067-B10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pd.5109","article-title":"Expanded carrier screening for monogenic disorders: Where are we now?","volume":"38","author":"Chokoshvili","year":"2018","journal-title":"Prenat Diagn"},{"key":"2021070807482399700_deab067-B11","first-page":"1","article-title":"UK guidelines for the medical and laboratory procurement and use of sperm, oocyte and embryo donors (2019)","volume":"6","author":"Clarke","year":"2019","journal-title":"Hum Fertil (Camb)"},{"key":"2021070807482399700_deab067-B12","author":"Cryos International","year":"2019"},{"key":"2021070807482399700_deab067-B13","author":"Cryos International","year":"2019"},{"key":"2021070807482399700_deab067-B14","author":"De Wert","year":"2020"},{"key":"2021070807482399700_deab067-B15","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/humrep\/deu111","article-title":"ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues","volume":"29","author":"Dondorp","year":"2014","journal-title":"Hum Reprod"},{"key":"2021070807482399700_deab067-B16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.fertnstert.2017.11.030","article-title":"Expanded carrier screening: what the reproductive endocrinologist needs to know","volume":"109","author":"Dungan","year":"2018","journal-title":"Fertil Steril"},{"key":"2021070807482399700_deab067-B17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/AOG.0000000000000666","article-title":"Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine","volume":"125","author":"Edwards","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2021070807482399700_deab067-B18","author":"Fabiani","year":"2020"},{"key":"2021070807482399700_deab067-B19","author":"Genetics Home Reference","year":"2020"},{"key":"2021070807482399700_deab067-B20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/gim.2013.47","article-title":"ACMG position statement on prenatal\/preconception expanded carrier screening","volume":"15","author":"Grody","year":"2013","journal-title":"Genet Med"},{"key":"2021070807482399700_deab067-B21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41431-017-0016-z","article-title":"Recent developments in genetics and medically-assisted reproduction: from research to clinical applications","volume":"26","author":"Harper","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"2021070807482399700_deab067-B22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/ejhg.2015.271","article-title":"Responsible implementation of expanded carrier screening","volume":"24","author":"Henneman","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"2021070807482399700_deab067-B24","doi-asserted-by":"crossref","first-page":"E265","DOI":"10.1016\/j.fertnstert.2017.07.793","article-title":"Recipients\u2019 perspectives regarding expanded carrier screening of gamete donors","volume":"108","author":"Jackson","year":"2017","journal-title":"Fertil Steril"},{"key":"2021070807482399700_deab067-B25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41436-018-0273-4","article-title":"The evolving landscape of expanded carrier screening: challenges and opportunities","volume":"21","author":"Kraft","year":"2019","journal-title":"Genet Med"},{"key":"2021070807482399700_deab067-B27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.fertnstert.2017.11.032","article-title":"Ethical quandaries around expanded carrier screening in third-party reproduction","volume":"109","author":"Mertes","year":"2018","journal-title":"Fertil Steril"},{"key":"2021070807482399700_deab067-B28","year":"2020"},{"key":"2021070807482399700_deab067-B29","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/humrep\/deaa088","article-title":"Expanded carrier screening should not be mandatory for gamete donors","volume":"35","author":"Pennings","year":"2020","journal-title":"Hum Reprod"},{"key":"2021070807482399700_deab067-B30","year":"2015"},{"key":"2021070807482399700_deab067-B31","author":"Retsinformation. Vejledning om sundhedspersoners og v\u00e6vscentres virksomhed og forpligtelser i forbindelse med assisteret reproduction","year":"2015"},{"key":"2021070807482399700_deab067-B32","author":"Riigi","year":"2015"},{"key":"2021070807482399700_deab067-B33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12687-019-00443-6","article-title":"Expanded universal carrier screening and its implementation within a publicly funded healthcare service","volume":"11","author":"Rowe","year":"2019","journal-title":"J Community Genet"},{"key":"2021070807482399700_deab067-B34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/gtmb.2016.0014","article-title":"Carrier screening is a deficient strategy for determining sperm donor eligibility and reducing risk of disease in recipient children","volume":"20","author":"Silver","year":"2016","journal-title":"Genet Test Mol Biomarkers"},{"key":"2021070807482399700_deab067-B35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.fertnstert.2009.01.139","article-title":"Genetic testing of sperm donors: survey of current practices","volume":"94","author":"Sims","year":"2010","journal-title":"Fertil Steril"},{"key":"2021070807482399700_deab067-B36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.rbmo.2010.05.012","article-title":"A universal carrier test for the long tail of Mendelian disease","volume":"21","author":"Srinivasan","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"2021070807482399700_deab067-B37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/AOG.0000000000002139","article-title":"Finding middle ground in constructing a clinically useful expanded carrier screening panel","volume":"130","author":"Stevens","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2021070807482399700_deab067-B38","first-page":"356","article-title":"Expanded carrier screening in gamete donors of Venezuela","volume":"21","author":"Urbina","year":"2017","journal-title":"JBRA Assist Reprod"},{"key":"2021070807482399700_deab067-B39","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/humrep\/dex272","article-title":"A closer look at expanded carrier screening from a PGD perspective","volume":"32","author":"Vas-de-Macedo","year":"2017","journal-title":"Hum Reprod"},{"key":"2021070807482399700_deab067-B42","author":"World Health Organisation (WHO","year":"2020"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/36\/6\/1702\/37948251\/deab067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/36\/6\/1702\/37948251\/deab067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T15:15:32Z","timestamp":1625757332000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/36\/6\/1702\/6220410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,11]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,4,11]]},"published-print":{"date-parts":[[2021,5,17]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deab067","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,4,11]]}}}